Xenon Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-11.68-11.01-42.0926.01
Price/Sales ratio
205.2831.815.252.98
Earnings per Share (EPS)
$-3.19$-3.39$-0.88$1.43

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
4.80-7.28-5.18-1.65-3.55-8.17-18.42-17.27-19.04-16.89-0.02-3.55
Price/Sales ratio
2.207.3766.16163.65N/A49.7916.5173.92253.03N/A0.2249.79
Price/Book Value ratio
0.851.881.861.411.183.693.102.473.303.320.003.69
Price/Cash Flow ratio
235.03-6.34-6.09-1.77-3.53-73.41-11.03-19.60-24.25-21.19-0.02-3.53
Price/Free Cash Flow ratio
-49.50-6.15-6.01-1.75-3.47-57.91-10.46-19.04-23.55-20.41-0.02-3.47
Price/Earnings Growth ratio
0.000.05-0.15-0.10-0.860.800.38-0.14-1.32-0.521.03-0.86
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
79.19%82.26%38.21%-8122.82%N/A-468.82%-57.06%-309.30%-1021.12%N/AN/AN/A
Operating Profit Margin
39.14%-60.09%-1376.42%-10474.27%N/A-627.01%-97.31%-428.44%-1368.91%N/A-909.21%-627.01%
Pretax Profit Margin
45.88%-101.12%-1275.48%-9872.66%N/A-609.43%-90.44%-427.87%-1327.69%N/A-942.89%-609.43%
Net Profit Margin
45.88%-101.12%-1275.48%-9872.66%N/A-609.09%-89.65%-427.84%-1328.94%N/A-932.93%-609.09%
Effective Tax Rate
N/A6.58%7.91%6.09%-14.24%0.05%0.88%0.00%-0.09%-0.15%1.05%-14.24%
Return on Assets
14.89%-24.63%-34.07%-66.57%-28.17%-28.16%-15.24%-13.79%-16.62%-18.90%-11.68%-28.17%
Return On Equity
17.88%-25.80%-35.98%-85.44%-33.39%-45.22%-16.82%-14.34%-17.37%-19.65%-17.47%-33.39%
Return on Capital Employed
15.18%-15.30%-38.79%-77.48%-32.13%-41.04%-17.94%-14.16%-17.65%-22.83%-11.89%-32.13%
Liquidity Ratios
Current Ratio
5.9421.8718.6710.9729.483.3312.29N/AN/AN/A18.163.33
Quick Ratio
5.9421.9918.6710.9729.483.3312.4239.2226.4823.6418.163.33
Cash ratio
5.0421.084.865.0116.440.573.0412.262.525.451.750.57
Days of Sales Outstanding
2.767.3840.48514.05N/A43.4520.6754.7338.14N/A38.1143.45
Days of Inventory outstanding
0.00-41.620.000.00N/AN/A-13.16-13.37-3.40N/AN/AN/A
Operating Cycle
2.76-34.2440.48514.05N/A43.457.5141.3634.74N/AN/A43.45
Days of Payables Outstanding
34.19143.77479.3417.8840.4523.2321.9618.4929.3018.73N/A23.23
Cash Conversion Cycle
-31.42-178.02-438.86496.16N/A20.21-14.4522.865.44N/AN/A20.21
Debt Ratios
Debt Ratio
N/AN/AN/A0.140.120.10N/AN/AN/AN/A0.040.10
Debt Equity Ratio
N/AN/AN/A0.180.140.16N/AN/AN/AN/A0.040.16
Long-term Debt to Capitalization
N/AN/AN/A0.140.120.10N/AN/AN/AN/AN/A0.10
Total Debt to Capitalization
N/AN/AN/A0.150.120.14N/AN/AN/AN/AN/A0.14
Interest Coverage Ratio
N/AN/AN/AN/A-27.27-29.85-64.67N/AN/AN/A-25.00-27.27
Cash Flow to Debt Ratio
N/AN/AN/A-4.22-2.31-0.29N/AN/AN/AN/AN/A-2.31
Company Equity Multiplier
1.201.041.051.281.181.601.101.031.041.031.041.60
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.00-1.16-10.85-92.36N/A-0.67-1.49-3.76-10.43N/A-10.42-0.67
Free Cash Flow / Operating Cash Flow Ratio
-4.741.031.011.011.011.261.051.021.021.031.021.01
Cash Flow Coverage Ratio
N/AN/AN/A-4.22-2.31-0.29N/AN/AN/AN/AN/A-2.31
Short Term Coverage Ratio
N/AN/AN/A-41.03N/A-0.99N/AN/AN/AN/A-9.43-0.99
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A